Ironwood Pharmaceuticals Stock Market Value
| IRWD Stock | USD 4.84 0.28 6.14% |
| Symbol | Ironwood |
Will Biotechnology sector continue expanding? Could Ironwood diversify its offerings? Factors like these will boost the valuation of Ironwood Pharmaceuticals. Market participants price Ironwood higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ironwood Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 10.468 | Earnings Share 0.18 | Revenue Per Share | Quarterly Revenue Growth 0.333 | Return On Assets |
Investors evaluate Ironwood Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ironwood Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Ironwood Pharmaceuticals' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Ironwood Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ironwood Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Ironwood Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.
Ironwood Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ironwood Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ironwood Pharmaceuticals.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Ironwood Pharmaceuticals on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Ironwood Pharmaceuticals or generate 0.0% return on investment in Ironwood Pharmaceuticals over 90 days. Ironwood Pharmaceuticals is related to or competes with Canopy Growth, Alpha Teknova, Lifecore Biomedical, Aurora Cannabis, BioAge Labs, Genelux Common, and Neuropace. Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestin... More
Ironwood Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ironwood Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ironwood Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.01 | |||
| Information Ratio | 0.2146 | |||
| Maximum Drawdown | 41.1 | |||
| Value At Risk | (6.70) | |||
| Potential Upside | 15.94 |
Ironwood Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ironwood Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ironwood Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Ironwood Pharmaceuticals historical prices to predict the future Ironwood Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1916 | |||
| Jensen Alpha | 1.49 | |||
| Total Risk Alpha | 0.8677 | |||
| Sortino Ratio | 0.3992 | |||
| Treynor Ratio | 0.7547 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ironwood Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ironwood Pharmaceuticals February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1916 | |||
| Market Risk Adjusted Performance | 0.7647 | |||
| Mean Deviation | 4.9 | |||
| Semi Deviation | 3.17 | |||
| Downside Deviation | 4.01 | |||
| Coefficient Of Variation | 438.93 | |||
| Standard Deviation | 7.46 | |||
| Variance | 55.61 | |||
| Information Ratio | 0.2146 | |||
| Jensen Alpha | 1.49 | |||
| Total Risk Alpha | 0.8677 | |||
| Sortino Ratio | 0.3992 | |||
| Treynor Ratio | 0.7547 | |||
| Maximum Drawdown | 41.1 | |||
| Value At Risk | (6.70) | |||
| Potential Upside | 15.94 | |||
| Downside Variance | 16.08 | |||
| Semi Variance | 10.08 | |||
| Expected Short fall | (6.90) | |||
| Skewness | 2.04 | |||
| Kurtosis | 5.38 |
Ironwood Pharmaceuticals Backtested Returns
Ironwood Pharmaceuticals appears to be risky, given 3 months investment horizon. Ironwood Pharmaceuticals holds Efficiency (Sharpe) Ratio of 0.15, which attests that the entity had a 0.15 % return per unit of risk over the last 3 months. By evaluating Ironwood Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.92% is justified by implied risk. Please utilize Ironwood Pharmaceuticals' Downside Deviation of 4.01, risk adjusted performance of 0.1916, and Market Risk Adjusted Performance of 0.7647 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ironwood Pharmaceuticals holds a performance score of 11. The company retains a Market Volatility (i.e., Beta) of 2.24, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ironwood Pharmaceuticals will likely underperform. Please check Ironwood Pharmaceuticals' maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to make a quick decision on whether Ironwood Pharmaceuticals' current trending patterns will revert.
Auto-correlation | 0.58 |
Modest predictability
Ironwood Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Ironwood Pharmaceuticals time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ironwood Pharmaceuticals price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current Ironwood Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | 0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 0.3 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ironwood Pharmaceuticals is a strong investment it is important to analyze Ironwood Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ironwood Pharmaceuticals' future performance. For an informed investment choice regarding Ironwood Stock, refer to the following important reports:Check out Ironwood Pharmaceuticals Correlation, Ironwood Pharmaceuticals Volatility and Ironwood Pharmaceuticals Performance module to complement your research on Ironwood Pharmaceuticals. For information on how to trade Ironwood Stock refer to our How to Trade Ironwood Stock guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Ironwood Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.